MATTHEWS, N.C.--(BUSINESS WIRE)--CEM Corporation, a leading provider of microwave laboratory instrumentation, is pleased to announce that the Company has recently sold its 100th automated microwave peptide synthesizer in only 2 years time. The Liberty™ Microwave Peptide Synthesizer was first introduced in February 2005. It has quickly become the most preferred peptide synthesizer available due to the unique benefits of microwave technology, and is being used by many well-known research facilities and companies including Scripps Research Institute, St. Jude Children’s Research Hospital, Hoffman LaRoche, University of Edinburgh (UK), Rockefeller University, Amgen, Mayo Clinic, and Kyoto University (Japan). Additionally, CEM has sold 40 of its Discover®SPS Systems, a manual version of the microwave peptide synthesizer. The use of microwave energy for solid-phase peptide synthesis allows peptides to be synthesized faster, often with higher purities than can be produced using traditional methods.
